Literature DB >> 24891298

microRNA-mediated survivin control of pluripotency.

Kristina Kapinas1, Heesun Kim, Matthew Mandeville, Lori A Martin-Buley, Carlo M Croce, Jane B Lian, Andre J van Wijnen, Janet L Stein, Dario C Altieri, Gary S Stein.   

Abstract

Understanding the mechanisms that sustain pluripotency in human embryonic stem cells (hESCs) is an active area of research that may prove useful in regenerative medicine and will provide fundamental information relevant to development and cancer. hESCs and cancer cells share the unique ability to proliferate indefinitely and rapidly. Because the protein survivin is uniquely overexpressed in virtually all human cancers and in hESCs, we sought to investigate its role in supporting the distinctive capabilities of these cell types. Results presented here suggest that survivin contributes to the maintenance of pluripotency and that post-transcriptional control of survivin isoform expression is selectively regulated by microRNAs. miR-203 has been extensively studied in human tumors, but has not been characterized in hESCs. We show that miR-203 expression and activity is consistent with the expression and subcellular localization of survivin isoforms that in turn modulate expression of the Oct4 and Nanog transcription factors to sustain pluripotency. This study contributes to understanding of the complex regulatory mechanisms that govern whether hESCs proliferate or commit to lineages.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24891298      PMCID: PMC4182148          DOI: 10.1002/jcp.24681

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  47 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.

Authors:  Linli Tian; Minghua Li; Jingchun Ge; Yan Guo; Yanan Sun; Ming Liu; Hui Xiao
Journal:  Tumour Biol       Date:  2014-04-01

3.  MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.

Authors:  Merav Bar; Stacia K Wyman; Brian R Fritz; Junlin Qi; Kavita S Garg; Rachael K Parkin; Evan M Kroh; Ausra Bendoraite; Patrick S Mitchell; Angelique M Nelson; Walter L Ruzzo; Carol Ware; Jerald P Radich; Robert Gentleman; Hannele Ruohola-Baker; Muneesh Tewari
Journal:  Stem Cells       Date:  2008-06-26       Impact factor: 6.277

4.  Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency.

Authors:  Amber N Mull; Amanda Klar; Christopher S Navara
Journal:  Stem Cell Res       Date:  2014-01-14       Impact factor: 2.020

5.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

Review 6.  Treat cancers by targeting survivin: just a dream or future reality?

Authors:  Mohane Selvaraj Coumar; Fang-Ying Tsai; Jagat Rakesh Kanwar; Sailu Sarvagalla; Chun Hei Antonio Cheung
Journal:  Cancer Treat Rev       Date:  2013-02-28       Impact factor: 12.111

7.  Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.

Authors:  Edward M Conway; Saskia Pollefeyt; Marta Steiner-Mosonyi; Wei Luo; Astrid Devriese; Florea Lupu; Francoise Bono; Nathalie Leducq; Frederique Dol; Paul Schaeffer; Désiré Collen; Jean-Marc Herbert
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

Review 8.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 9.  Cell cycle dependent phosphorylation and subnuclear organization of the histone gene regulator p220(NPAT) in human embryonic stem cells.

Authors:  Prachi N Ghule; Klaus A Becker; J Wade Harper; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  J Cell Physiol       Date:  2007-10       Impact factor: 6.384

10.  miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells.

Authors:  Lifeng Miao; Xianze Xiong; Yixin Lin; Yao Cheng; Jiong Lu; Jie Zhang; Nansheng Cheng
Journal:  Oncol Lett       Date:  2014-01-16       Impact factor: 2.967

View more
  6 in total

Review 1.  Survivin - The inconvenient IAP.

Authors:  Dario C Altieri
Journal:  Semin Cell Dev Biol       Date:  2015-01-12       Impact factor: 7.727

2.  Cell cycle gene expression networks discovered using systems biology: Significance in carcinogenesis.

Authors:  Robert E Scott; Prachi N Ghule; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

Review 3.  Regulators of pluripotency and their implications in regenerative medicine.

Authors:  Ahmed El-Badawy; Nagwa El-Badri
Journal:  Stem Cells Cloning       Date:  2015-04-21

Review 4.  The Genomic Health of Human Pluripotent Stem Cells: Genomic Instability and the Consequences on Nuclear Organization.

Authors:  Marianne P Henry; J Ross Hawkins; Jennifer Boyle; Joanna M Bridger
Journal:  Front Genet       Date:  2019-01-21       Impact factor: 4.599

Review 5.  MicroRNAs: From Female Fertility, Germ Cells, and Stem Cells to Cancer in Humans.

Authors:  Irma Virant-Klun; Anders Ståhlberg; Mikael Kubista; Thomas Skutella
Journal:  Stem Cells Int       Date:  2015-11-09       Impact factor: 5.443

Review 6.  Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.